« Resveratrol research profiled. | Home | Sanofi-Aventis Shipping H1N1 Vaccine To US Government Tuesday »
Double dose of Plavix better for certain angioplasty patients
By jeremyc | September 29, 2009
HealthDay (9/28, Edelson) reported that “cardiologists are looking at the next generation of clot-busters that could replace Plavix [clopidogrel].” In a study “published in the Oct. 6 issue of the Journal of the American College of Cardiology,” researchers “found that a 600-milligram dose of Plavix is more effective than a 300-milligram dose during angioplasty for people with the most severe form of heart attack.” The investigators “found a 28 percent lower incidence of death and major coronary problems in those who received the higher dose.”
Topics: | Clopidogrel, Plavix |
Comments are closed.
